Anagestone
Anagestone (INN), also known as 3-deketo-6α-methyl-17α-hydroxyprogesterone or as 6α-methyl-17α-hydroxypregn-4-en-20-one, is a progestin which was never marketed.[1]
![]() | |
Clinical data | |
---|---|
Other names | Anapregnone; 3-Deketo-6α-methyl-17α-hydroxyprogesterone; 6α-Methyl-17α-hydroxypregn-4-en-20-one |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C22H34O2 |
Molar mass | 330.512 g·mol−1 |
3D model (JSmol) | |
| |
|
An acylated derivative, anagestone acetate, was formerly used clinically as a pharmaceutical drug.[1]
While anagestone is sometimes used as a synonym for anagestone acetate, it usually refers to anagestone acetate, not anagestone.
References
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 85–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.